MEA Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Middle East and Africa Thyroid Cancer Diagnostics Market, By Product Type (Instruments, Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, Others), Cancer Type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group (30-65, 65 and Above, 21-29, Below 21), End Users (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, Rest of Middle East and Africa) Industry Trends and Forecast to 2030
Market Definition:
Thyroid cancer is a type of cancer that begins in the par follicular and follicular thyroid cells of the thyroid gland. Thyroid cancer treatment options include surgical removal of the thyroid gland, radioactive ablation, and TSH suppression therapy. Iodine is absorbed by thyroid cells and converted into triiodothyronine (T3) and thyroxine. These hormones are released into the bloodstream and play an important role in the regulation of metabolism. A healthy thyroid gland produces approximately 80% T4 and 20% T3.
Market Segmentation:
The Middle East and Africa thyroid cancer diagnostics market is categorized into seven notable segments based on product type, test type, cancer type, stages, age group, end user, and distribution channel.
• On the basis of product type, the Middle East and Africa thyroid cancer diagnostics market is segmented into instruments and consumables & accessories
• On the basis of test type, the Middle East and Africa thyroid cancer diagnostics market is segmented into imaging test, blood test, biopsy, and others
• On the basis of Cancer type, the Middle East and Africa thyroid cancer diagnostics market is segmented into papillary carcinoma, follicular carcinoma, others
• On the basis of Stage, the Middle East and Africa thyroid cancer diagnostics market is segmented into Stage I, Stage II, Stage III, Stage IV)
• On the basis of Age group, the Middle East and Africa thyroid cancer diagnostics market is segmented into 30-65, 65 and above, 21-29, below 21
• On the basis of end user, the Middle East and Africa thyroid cancer diagnostics market is segmented into hospitals, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, others
• On the basis of distribution channel, the Middle East and Africa thyroid cancer diagnostics market is segmented into direct tender and retail sales
Market Players
Some of the major players operating in the Middle East and Africa thyroid cancer diagnostics market are:
• FUJIFILM Holdings Corporation
• F. Hoffmann-La Roche Ltd
• Quest Diagnostics Incorporated
• Illumina
• Koninklijke Philips N.V.
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Abbott
• General Electric Company
• QIAGEN
• DIASORIN S.P.A.
• Merck KGaA
• Hologic
• Myriad Genetics Inc.
• BIOMERIEUX
• FONAR Corp.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook